Palmer Luckey and Ben Lamm Launch Startup for Genetically Enhanced Military Dogs
Warhound, a Texas startup founded by Anduril's Palmer Luckey and Colossal Biosciences cofounder Ben Lamm, has raised $200 million. It plans to use gene editing and cloning to produce working dogs for the military, police and first responders.
A new US startup, Warhound, has emerged from stealth with the stated aim of creating genetically enhanced dogs for the military, law enforcement and emergency first responders. It was conceived by Palmer Luckey of the defense technology company Anduril and Ben Lamm, cofounder of the biotechnology firm Colossal Biosciences. The company has raised $200 million to rebuild the country's domestic supply of elite working dogs and reduce reliance on European breeders, which currently supply military canines.
Cloning and gene editing
Lamm told WIRED that Warhound is already gene-editing its first batch of dogs. Blood samples have been collected from top-performing military, police and first responder dogs in the United States, and the goal is to clone them. The breeds will be mostly Belgian Malinois, with some labradors and some shepherds. The first puppies are expected in early 2027.
The first rounds of editing will target common health problems in these breeds, such as hip dysplasia. Later, Lamm envisions more ambitious changes, including adding olfactory receptor genes from wolves to enhance the dogs' sense of smell. Colossal Biosciences is best known for its work on gene-edited wolves in its Dire Wolf De-Extinction Project.
Equipment and leadership
According to a press release, the Texas-based company will also equip the dogs with Anduril's advanced cybernetic augments, software and battlefield situational awareness. Lamm clarified that the current plan involves tools such as advanced body armor rather than computers embedded in the animals. Asked about lasers, he said he could not comment on Anduril's plans, stressing that the priorities are dog safety and performance and strengthening the bond between handler and dog.
Neither Luckey nor Lamm will take part in daily operations, although Lamm sits on the board. David Spirk, a former Department of Defense chief data officer who most recently worked at Palantir, is chief executive. Investors include In-Q-Tel, Sequoia Capital and ARK Invest. Luckey is not an owner and holds no equity, nor does Anduril; Colossal Biosciences does have an ownership stake. The company says it will operate under the guidance of the American Humane Society.
